This causes continuous activation of the PKC and NF-κB pathways (Giorgi et al, 2010; Lingappan, 2018), perpetuating a cycle of ROS-induced cell damage, dysregulation of gene expression, and prolonged inflammation even in the absence of hyperglycemia. The gene discussed is PRRT2; the disease is Hyperglycemia.